NCT02932826View on ClinicalTrials.gov

Safety Study and Therapeutic Effects of Umbilical Cord Blood Treg on Autoimmune Diabetes

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

October 31, 2016

Primary Completion Date

June 30, 2025

Study Completion Date

November 30, 2025

Conditions
Diabetes Mellitus, Type 1
Interventions
BIOLOGICAL

Umbilical Cord Blood Regulatory T cells Therapy

Receive Treg infusion: 1\~5\*10\^6/kg b.w. in 100ml NS

DRUG

Insulin

Treated according to routine clinical practice at the discretion of the treating physician

Trial Locations (1)

410011

RECRUITING

Institute of Metabolism and Endocrinology, Second Xiangya Hospital, Central South University, Changsha

All Listed Sponsors
lead

Second Xiangya Hospital of Central South University

OTHER